HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer

International Journal of Oncology

Volumn 43, Issue 5, 2013, Pages 1431-1440

  Miyake, Shuusuke ^a   Kitajima, Yoshihiko ^a,b   Nakamura, Jun ^a   Kai, Keita ^a   Yanagihara, Kazuyoshi ^c   Tanaka, Tomokazu ^a   Hiraki, Masatsugu ^a   Miyazaki, Kohji ^a   Noshiro, Hirokazu ^a  

^a SAGA UNIVERSITY   (Japan)

^b Miyaki gun   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Angiogenesis; Gastric cancer; HIF 1 ; Peritoneal dissemination

Indexed keywords

CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LYVE 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CELL INVASION; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PERITONEUM METASTASIS; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR INVASION; TUMOR SEEDING;

ADENOCARCINOMA, SCIRRHOUS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL PROLIFERATION; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 84885061734     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2068     Document Type: Article

References (30)

1. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL and Thun MJ: Global Cancer Facts and Figures 2007. American Cancer Society, Atlanta, GA, 2007.
2. Chu DZ, Lang NP, Thompson C, Osteen PK and Westbrook KC: Peritoneal carcinomatosis in non gynecologic malignancy. A prospective study of prognostic factors. Cancer 63: 364-367, 1989.
3. Yonemura Y, Kawamura T, Bandou E, Tsukiyama G, Endou Y and Miura M: The natural history of free cancer cells in the peritoneal cavity. In: Advances in Peritoneal Surface Oncology. Gonzalez-Moreno S (ed). Springer, Berlin, pp11-23, 2007.
4. Kotanagi H, Saito Y, Shiozawa N and Koyama K: Establishment of a human cancer cell line with high potential for peritoneal dissemination. J Gastroenterol 30: 437-438, 1995.
5. Yanagihara K, Takigahira M, Tanaka H, et al: Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci 96: 323-332, 2005.
6. Takei Y, Takigahira M, Mihara K, Tarumi Y and Yanagihara K: The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Cancer Res 71: 1442-1453, 2010.
7. Wang GL and Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90: 4304-4308, 1993.
8. Semenza GL: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8: S62-7, 2002.
9. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
10. Kitajima Y and Miyazaki K: The critical impact of HIF-1α on gastric cancer biology. Cancers 5: 15-26, 2013.
11. Sumiyoshi Y, Kakeji Y, Egashira A, Mizokami K, Orita H and Maehara Y: Overexpression of hypoxia-inducible factor 1α and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 12: 5112-5117, 2006.
12. Koukourakis MI, Giatromanolaki A, Skarlatos J, et al: Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 61: 1830-1832, 2001.
13. Bos R, van der Groep P, Greijer AE, et al: Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581, 2003.
14. Nakanishi K, Hiroi S, Tominaga S, et al: Expression of hypoxia-inducible factor-1α protein predicts survival in patients with tranitional cell carcinoma of the upper urinary tract. Clin Cancer Res 11: 2583-2590, 2005.
15. Birner P, Schindl M, Obermair A, Breitenecker G and Oberhuber G: Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 7: 1661-1668, 2001.
16. Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H and Miyazaki K: HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy. Int J Cancer 127: 1158-1171, 2010.
17. Ide T, Kitajima Y, Miyoshi A, et al: Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway. Int J Cancer 119: 2750-2759, 2006.
18. Kitajima Y, Ide T, Ohtsuka T and Miyazaki K: Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci 99: 1341-1347, 2008.
19. Liu L, Sun L, Zhang H, et al: Hypoxia-mediated up-regulation of MGr1-Ag/37LRP in gastric cancers occurs via hypoxia-inducible-factor 1-dependent mechanism and contributes to drug resistance. Int J Cancer 124: 1707-1715, 2009.
20. Song IS, Wang AG, Yoon SY, Kim JM, Kim JH, Lee DS and Kim NS: Regulation of glucose metabolism-related genes and VEGF by HIF-1α and HIF-1β, but not HIF-2α, in gastric cancer. Exp Mol Med 41: 51-58, 2009.
21. Zhang R, Fu H, Chen D, Hua J, Hu Y, Sun K and Sun X: Subcellular distribution of S100A4 and its transcriptional regulation under hypoxic conditions in gastric cancer cell line BGC823. Cancer Sci 101: 1141-1146, 2010.
22. Liu L, Ning X, Sun L, et al: Hypoxia-inducible factor-1α contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99: 121-128, 2008.
23. Miyoshi A, Kitajima Y, Ide T, et al: Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1α-independent manner. Int J Oncol 29: 1533-1539, 2006.
24. Xin L and Yibin K: Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 16: 5928-5935, 2010.
25. Hiraki M, Kitajima Y, Kai K, Nakamura J, Hashiguchi K, Noshiro H and Miyazaki K: Knockdown of hypoxia-inducible factor-1a accelerates peritoneal dissemination via the upregulation of MMP-1 expression in gastric cancer cell lines. Exp Ther Med 4: 355-362, 2012.
26. Liotta LY: Tumor invasion and metastases - role of the extracellular matirix: Rhoads Memorial Award lecture. Cancer Res 46: 1-7, 1986.
27. Kawamura T, Endo Y, Yonemura Y, et al: Significance of integrin alpha2/beta1 in peritoneal dissemination of a human gastric cancer xenograft model. Int J Oncol 18: 809-815, 2001.
28. Stoeltzing O, McCarty MF, Wey JS, et al: Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis and vessel maturation. J Natl Cancer Inst 96: 946-956, 2004.
29. Albrecht I and Christofori G: Molecular mechanisms of lymphangiogenesis in development and cancer. Int J Dev Biol 55: 483-494, 2011.
30. Silverman MP: The subperitoneal space: mechanisms of tumor spread in the peritoneal cavity, mesentery and omentum. Cancer Imaging 4: 25-29, 2003.